Skip to main
ZYXI
ZYXI logo

Zynex Inc (ZYXI) Stock Forecast & Price Target

Zynex Inc (ZYXI) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Zynex Inc. reported a 16% year-over-year growth in orders for Fiscal Year 2024, indicating a robust demand for its electrotherapy and pain management products. The company's focus on enhancing revenue per sales representative to $1 million, alongside positive clinical study results for its laser-based system, positions Zynex strongly within the medical device sector as a leader in non-opioid pain management solutions. Additionally, a projected annual savings of approximately $35 million from expense reductions in the second half of 2025 and the first quarter of 2025 further enhances the company's financial outlook, potentially leading to increased profitability and market share growth.

Bears say

Zynex Inc has indicated a significant downturn in its financial outlook, with projected Q1 2025 sales of at least $30 million, highlighting a decline of 37% year-over-year and a 35% sequential decrease. The company's Q4 2024 total revenue was reported at $46 million, reflecting a 3% decline year-over-year and a notable shortfall against earlier projections. Furthermore, Zynex's earnings report showed an EPS loss of $0.30, compounded by reduced sales expectations for 2025, which are now modeled at $140 million, representing a 28% decrease year-over-year, thus underscoring concerns about operational visibility and ongoing business challenges.

Zynex Inc (ZYXI) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zynex Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zynex Inc (ZYXI) Forecast

Analysts have given Zynex Inc (ZYXI) a Buy based on their latest research and market trends.

According to 6 analysts, Zynex Inc (ZYXI) has a Buy consensus rating as of Sep 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zynex Inc (ZYXI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.